Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells

Veterinary Microbiology

Volumn 147, Issue 1-2, 2011, Pages 75-82

  Surendran, Naveen ^a   Hiltbold, Elizabeth M ^b   Heid, Bettina ^a   Sriranganathan, Nammalwar ^a   Boyle, Stephen M ^a   Zimmerman, Kurt L ^a   Makris, Melissa R ^a   Witonsky, Sharon G ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Brucella abortus; Dendritic cells; Innate immunity

Indexed keywords

2308; BRUCELLA VACCINE; INTERLEUKIN 12P70; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RB 51; RB 51SOD; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; BRUCELLA ABORTUS ROUGH VACCINE STRAIN RB51; BRUCELLA ABORTUS ROUGH VACCINE STRAIN RB51SOD; BRUCELLA ABORTUS SMOOTH STRAIN 2308; BRUCELLOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PROTEIN ANALYSIS; STRAIN DIFFERENCE; UPREGULATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; BONE MARROW CELLS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS, BOVINE; CATTLE; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-12; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

BOS; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; MURINAE; NEGIBACTERIA;

EID: 77957370294     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.06.001     Document Type: Article

References (17)

1. Acha P., Szyfres B. Zoonoses and Communicable Diseases Common to Man and Animal 2001, Pan American Health Organization, WHO.
2. Ashford D.A., di Pietra J., Lingappa J., Woods C., Noll H., Neville B., Weyant R., Bragg S.L., Spiegel R.A., Tappero J., Perkins B.A. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 2004, 22:3435-3439.
3. Billard E., Cazevieille C., Dornand J., Gross A. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect Immun 2005, 73:8418-8424.
4. Billard E., Dornand J., Gross A. Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect Immun 2007, 75:4980-4989.
5. Billard E., Dornand J., Gross A. Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect Immun 2007, 75:5916-5923.
6. Billard E., Dornand J., Gross A. VirB type IV secretory system does not contribute to Brucella suis' avoidance of human dendritic cell maturation. FEMS Immunol Med Microbiol 2008, 53:404-412.
7. Corbel M.J. Brucellosis in Humans and Animals 2006, World Health Organization.
8. Gonzalez D., Grillo M.J., De Miguel M.J., Ali T., Arce-Gorvel V., Delrue R.M., Conde-Alvarez R., Munoz P., Lopez-Goni I., Iriarte M., Marin C.M., Weintraub A., Widmalm G., Zygmunt M., Letesson J.J., Gorvel J.P., Blasco J.M., Moriyon I. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS One 2008, 3:e2760.
9. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
10. Macedo G.C., Magnani D.M., Carvalho N.B., Bruna-Romero O., Gazzinelli R.T., Oliveira S.C. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection. J Immunol 2008, 180:1080-1087.
11. Olsen S.C., Boyle S.M., Schurig G.G., Sriranganathan N.N. Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin Vaccine Immunol 2009, 16:535-540.
12. Salcedo S.P., Marchesini M.I., Lelouard H., Fugier E., Jolly G., Balor S., Muller A., Lapaque N., Demaria O., Alexopoulou L., Comerci D.J., Ugalde R.A., Pierre P., Gorvel J.P. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog 2008, 4:e21.
13. Schurig G.G., Roop R.M., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 1991, 28:171-188.
14. Sriranganathan N., Boyle S., Schrurig G., Misra H. Superoxide dismutases of virulent and avirulent strains of Brucella abortus. Vet Microbiol 1991, 26:359-366.
15. Vemulapalli R., He Y., Cravero S., Sriranganathan N., Boyle S.M., Schurig G.G. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun 2000, 68:3286-3289.
16. Vemulapalli R., McQuiston J.R., Schurig G.G., Sriranganathan N., Halling S.M., Boyle S.M. Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin Diagn Lab Immunol 1999, 6:760-764.
17. Zwerdling A., Delpino M.V., Barrionuevo P., Cassataro J., Pasquevich K.A., Garcia Samartino C., Fossati C.A., Giambartolomei G.H. Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus. Microbes Infect 2008, 10:1346-1354.